Physician profile
Fadi Layous
NPI 1912955584
$63,891.65
in general payments reported to CMS, 2019-2025
58 companies · $3,275 in 2025
The $3,275 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,700 · 2020: $5,040 · 2021: $24K · 2022: $12K · 2023: $8,380 · 2024: $4,262 · 2025: $3,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,287 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,335 · Education: $1,821 · Travel and Lodging: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,286.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,335.00 |
| Education | $1,821.03 |
| Travel and Lodging | $474.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $34,651.38 | 2019-2025 | Xywav |
| Mylan Specialty L.P. | $9,619.10 | 2019-2024 | Yupelri |
| Intuitive Surgical, INC. | $2,456.63 | 2023-2025 | Da Vinci Surgical System |
| Ethicon INC. | $1,956.23 | 2019-2023 | Monarch Platform |
| Astrazeneca Pharmaceuticals LP | $1,937.46 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,485.52 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Covidien LP | $926.33 | 2019 | |
| Inspire Medical Systems, INC. | $890.43 | 2019-2025 | Inspire |
| Harmony Biosciences LLC | $792.23 | 2020-2025 | Wakix |
| Mallinckrodt Hospital Products INC. | $561.34 | 2020-2024 | Acthar |
| Grifols USA, LLC | $559.19 | 2020-2025 | Xembify, Prolastin-C Liquid |
| Bayer Healthcare Pharmaceuticals INC. | $505.39 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $478.25 | 2019-2025 | Ofev |
| Actelion Pharmaceuticals US, INC. | $472.12 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Genzyme Corporation | $456.50 | 2021-2025 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $449.50 | 2023-2025 | Lumryz |
| Boston Scientific Corporation | $436.94 | 2019-2023 | Spyglass |
| Regeneron Healthcare Solutions, INC. | $306.80 | 2019-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $305.64 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $292.87 | 2020-2025 | Glassia |
| Baxter Healthcare | $286.14 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| E.R. Squibb & Sons, L.L.C. | $281.29 | 2019-2023 | Zeposia |
| Genentech USA, INC. | $259.24 | 2019-2025 | Xolair |
| United Therapeutics Corporation | $257.43 | 2023-2025 | Tyvaso, Tyvaso |
| Axsome Therapeutics, INC. | $250.66 | 2023-2025 | Sunosi |
| Ani Pharmaceuticals, INC. | $239.74 | 2024-2025 | Purified Cortrophin Gel |
| Itamar Medical INC | $237.05 | 2023 | Watchpatone |
| Philips North America LLC | $185.82 | 2020-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Verona Pharma, INC. | $184.34 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $180.13 | 2019-2025 | Winrevair |
| Zoll Respicardia, INC. | $176.25 | 2021 | |
| Electromed, INC. | $176.08 | 2021-2025 | Smartvest |
| Galvanize Therapeutics, INC | $168.05 | 2025 | Aliya System |
| Insmed, INC. | $161.68 | 2022-2025 | Arikayce, Brinsupri |
| Amgen INC. | $157.56 | 2022-2025 | Tezspire |
| Advanced Respiratory, INC | $131.18 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $121.08 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $83.63 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $80.58 | 2022-2024 | Quviviq |
| Pulmonx Corporation | $80.13 | 2021-2022 | |
| Viatris Specialty LLC | $73.49 | 2025 | Yupelri |
| Resmed Corp | $64.83 | 2023-2025 | |
| Inogen, INC. | $63.92 | 2025 | |
| Pfizer INC. | $56.69 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $48.82 | 2020-2021 | |
| Ambu INC. | $28.50 | 2022 | |
| Pharming Healthcare, INC. | $24.90 | 2023 | Ruconest |
| Arbor Pharmaceuticals, INC. | $24.27 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $24.27 | 2020 | |
| Siemens Medical Solutions USA, INC. | $21.80 | 2025 | Cios Spin |
| Lilly USA, LLC | $20.89 | 2025 | Zepbound |
| Optinose US, INC. | $20.87 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.90 | 2023 | Lifevest |
| Hikma Pharmaceuticals USA | $19.03 | 2023 | Ryaltris |
| Abbvie INC. | $18.68 | 2024 | |
| Erbe USA INC | $17.00 | 2023 | Erbe |
| Sunovion Pharmaceuticals INC. | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Layous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.